Trump lines up MFN deals with nine mid-size pharmas on drug pricing push

PartnershipNegative

AI Analysis

Summary

The Trump administration has negotiated MFN pricing deals with nine midsize pharmaceutical companies requiring them to provide MFN prices to state Medicaid programs nationally as part of a drug pricing initiative.

Outcome Details

White House MFN (Most Favored Nation) pricing agreements with nine midsize pharmaceutical companies requiring provision of MFN prices to state Medicaid programs nationally

Importance:5/10

Sentiment:

-0.40

drug pricingregulatoryMedicaidMFN pricingWhite House initiative

Read the original article

Published by Pharmaceutical Technology on September 1, 2026 11:05 AM

Read Original